Cochlear Limited (COH) - Product Pipeline Analysis
Reference Code: GDME4946PD Publication Date: MAY 2011
Company Snapshot Company Overview
Key Information
Cochlear Limited (Cochlear) is engaged in the development and
Cochlear Limited, Key Facts manufacture of electronic implantable hearing devices. The company’s
products are suited for people with hearing loss caused by ear nerve
Web Address www.cochlear.com
damage. The Cochlear Nucleus 5 System provides a hearing solution to
Turnover (in USD Million) 674.10 deliver hearing outcomes for both adults and children. The company
mainly operates in the US, Australia, and Europe. It markets and
Number of Employees 2,006 distributes its products worldwide through its subsidiaries. The company is
Industry Pharmaceuticals and Healthcare headquartered in New South Wales, Australia
Source:Primary / Secondary Research
GlobalData
Cochlear Limited Pipeline Products
Cochlear Limited Key Pipeline Products by Equipment Cochlear Limited Key Pipeline Products by Therapy Area
Type
Equipment Type No of Products Therapy Area No of Products
Hearing Implants 3 Hearing impairment 2
Meniere's Disease 1
Source: Primary / Secondary Research Source: Primary / Secondary Research
GlobalData GlobalData
Cochlear Limited Key Pipeline Products by Development Stage
Developmental Stage No of Products
Clinicals 3
Pre-Clinicals -
Early development -
Source: Primary / Secondary Research
GlobalData
Note : (-) indicates 'Not Available'
Cochlear Limited Key Pipeline Products by Trial Phase
Trial Phase No of Products
Phase IV -
Phase III -
Phase II -
Phase I -
Source: Primary / Secondary Research
GlobalData
Note : (-) indicates 'Not Available'
Cochlear Limited (COH) - Product Pipeline Analysis Reference Code: GDME4946PD
Source : www.globalcompanyintelligence.com Page 1
Table of Contents
Table of Contents................................................................................................................................................................................................................................................................... 2
List of Tables .......................................................................................................................................................................................................................................................................... 3
List of Figures......................................................................................................................................................................................................................................................................... 3
Cochlear Limited - Business Description ............................................................................................................................................................................................................................... 4
Key Facts ............................................................................................................................................................................................................................................................................... 4
Cochlear Limited - Major Products and Services ................................................................................................................................................................................................................... 5
Cochlear Limited Pipeline Products by Equipment Type................................................................................................................................................................................................. 6
Cochlear Limited Pipeline Products by Development Stage ........................................................................................................................................................................................... 8
Cochlear Limited Pipeline Products by Therapy Area ................................................................................................................................................................................................... 10
Cochlear Hybrid System ................................................................................................................................................................................................................................................ 12
Product Status......................................................................................................................................................................................................................................................... 12
Product Description ................................................................................................................................................................................................................................................. 12
Direct Acoustic Cochlear Stimulator (DACS)................................................................................................................................................................................................................. 12
Product Status......................................................................................................................................................................................................................................................... 12
Product Description ................................................................................................................................................................................................................................................. 12
Product Institution Details ....................................................................................................................................................................................................................................... 12
Implantable Device - Meniere's Disease ....................................................................................................................................................................................................................... 12
Product Status.............................................................................................................................